IL-17: a new actor in IFN-driven systemic autoimmune diseases.
about
Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus ErythematosusImmune heterogeneity in neuroinflammation: dendritic cells in the brainP2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?Treating multiple sclerosis with monoclonal antibodies: a 2013 update.Targeting of type I interferon in systemic autoimmune diseasesThe cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010.Serum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method.Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic ArthritisLong-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature.Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in miceA pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.Milk fat globule E-8 and interleukin 17 in systemic lupus erythematosus: partners in crime?The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant.Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosusInteractions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Emerging new roles of Th17 cells.Perspectives of the relationship between IL-7 and autoimmune diseases.Type I IFN signature in primary Sjögren's syndrome patients.Allergen immunotherapy, routes of administration and cytokine networks: an update.A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.TH17 cells, interleukin-17 and interferon-γ in patients and households contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment.AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating AutoantibodiesGene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy.Rheumatic diseases and the microbiomeDiminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome.Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.IL-33 neutralization suppresses lupus disease in lupus-prone mice.MicroRNA Expression Profiling in Behçet's Disease.Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.
P2860
Q26773124-84C2ED22-5EFE-45F4-BD44-771034FC76BAQ28385127-B9231242-BE48-4E21-9615-C515520CB7DEQ30409205-A0FB2065-DE41-43DC-B180-716A8A53FFB0Q33765598-A86C85E8-AAF3-49AC-B5B8-52175C69CA07Q34330211-FFB20651-50F8-4649-AC9E-9A991EAB8411Q34451758-0C8E2E0F-F6AE-411C-920F-62DB5086E1FEQ35075908-1D9D609F-1C79-418E-A0C7-ED7D3D97C9BFQ35631856-99E05164-79A7-4F3D-8446-9DED25E9F9DCQ35667354-036DD7A4-09C5-4B5F-833A-469EBE87B6A9Q36202783-D2CFEE21-EBC1-4184-B6F2-75E44EE0D65BQ36492808-201D96EC-8C75-406B-A762-8F9F21E292D8Q36549197-E5774F2F-B4CD-46EE-99F3-C8331BE2F345Q36842384-F2EE5127-38C3-4FF2-999C-895510A4E4FEQ37040371-FD723627-0491-4147-A412-3370ABEFC588Q37154827-5AABFDC5-C2D8-4422-8C22-FFE4C6ED0B5CQ37316252-9C630412-0B40-4CBD-B57E-681EBAB7EE3AQ37737549-8E72BF7E-E343-43A4-B937-BA643D6F2A2AQ38040739-9E284062-F5A4-4EEB-B140-144193C2BF3CQ38128224-AA7DE569-1ADC-421D-99C6-DA287D886135Q38180717-128C1766-CF89-4927-852E-3F6EBDD148D2Q38245926-29984EFD-ABC8-49A8-9574-A921E487EB1AQ38537618-E4DC3BB1-B80A-44B5-9F2B-F6B278C3FADBQ38799600-904224CE-4013-4496-9502-A98939F09FD9Q38964478-C724C323-2000-40F7-83BF-116219257724Q41819064-5C6E369B-03A3-4038-9A5E-192ADFCDAF2FQ42081086-C30D6992-5D0D-4586-ADC5-05F93B591F4CQ42582660-344BEA72-890E-4B3F-9641-566501AF8F93Q49906688-4EA9B788-767D-422D-9BE0-EC078A2A88AFQ52902188-264F1DDD-A618-4B54-9B2D-91ACF36A3A9AQ52944545-45FABA3A-3F2C-49EC-9D9D-814D3B6331F5Q54323094-992C0384-0EAF-4C63-80F9-298014BDE137Q55101372-7B280125-C30E-47CF-A8C2-2623805164DAQ55140887-95E00B70-7716-4323-8655-B7A347C030BA
P2860
IL-17: a new actor in IFN-driven systemic autoimmune diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
IL-17: a new actor in IFN-driven systemic autoimmune diseases.
@en
type
label
IL-17: a new actor in IFN-driven systemic autoimmune diseases.
@en
prefLabel
IL-17: a new actor in IFN-driven systemic autoimmune diseases.
@en
P2860
P356
P1476
IL-17: a new actor in IFN-driven systemic autoimmune diseases.
@en
P2093
Alexander Espinosa
Aurélie Ambrosi
P2860
P304
P356
10.1002/EJI.201242653
P407
P577
2012-09-01T00:00:00Z